Filtered By:
Source: International Journal of Cardiology
Condition: Atrial Fibrillation

This page shows you your search results in order of relevance. This is page number 15.

Order by Relevance | Date

Total 388 results found since Jan 2013.

Pharmacology, benefits, unaddressed questions, and pragmatic issues of the newer oral anticoagulants for stroke prophylaxis in non-valvular atrial fibrillation and proposal of a management algorithm
Source: International Journal of Cardiology - April 26, 2014 Category: Cardiology Authors: Salvatore Rosanio, Abdul M. Keylani, Darrin C. D'Agostino, Craig M. DeLaughter, Antonio Vitarelli Source Type: research

Short stature and ischemic stroke in nonvalvular atrial fibrillation: New insight into the old observation
Source: International Journal of Cardiology - April 21, 2014 Category: Cardiology Authors: Jeonggeun Moon, Hye-Jeong Lee, Young Jin Kim, Jong-Youn Kim, Hui-Nam Pak, Jong-Won Ha, Moon-Hyoung Lee, Boyoung Joung Source Type: research

The use of direct oral anticoagulants for stroke prevention in atrial fibrillation: A study on physicians' perspective and preferences
Source: International Journal of Cardiology - April 28, 2014 Category: Cardiology Authors: Alexander Wutzler, Marwin Bannehr, Ann Cathrin Pöhlmann, Wilhelm Haverkamp Source Type: research

Pharmacology, benefits, unaddressed questions, and pragmatic issues of the newer oral anticoagulants for stroke prophylaxis in non-valvular atrial fibrillation and proposal of a management algorithm
Source: International Journal of Cardiology - April 26, 2014 Category: Cardiology Authors: Salvatore Rosanio, Abdul M. Keylani, Darrin C. D'Agostino, Craig M. DeLaughter, Antonio Vitarelli Source Type: research

Short stature and ischemic stroke in nonvalvular atrial fibrillation: New insight into the old observation
Source: International Journal of Cardiology - April 21, 2014 Category: Cardiology Authors: Jeonggeun Moon, Hye-Jeong Lee, Young Jin Kim, Jong-Youn Kim, Hui-Nam Pak, Jong-Won Ha, Moon-Hyoung Lee, Boyoung Joung Source Type: research

Comparative evaluation of HAS-BLED and ATRIA scores by investigating the full potential of their bleeding prediction schemes in non-valvular atrial fibrillation patients on vitamin-K antagonists
Although vitamin K antagonists (VKAs) greatly reduce the risk of stroke in non-valvular atrial fibrillation (NVAF), the risk of bleeding with this therapy remains challenging [1]. HAS-BLED [2,3] and ATRIA [4] are currently the most popular scoring systems for bleeding risk assessment in NVAF. Until now, the main studies [5–7] compared both scores used “modified” versions of the original scores, whilst the current recommendation [3] is to use HAS-BLED as it was originally conceived. Furthermore, most of these studies came from trial population or hospitalized patients [5,7].
Source: International Journal of Cardiology - August 7, 2014 Category: Cardiology Authors: Rami Riziq-Yousef Abumuaileq, Emad Abu-Assi, Sergio Raposeiras-Roubin, Andrea López-López, Alfredo Redondo-Diéguez, Diego Álvarez-Iglesias, Moisés Rodríguez-Mañero, Carlos Peña-Gil, Jose Ramón González-Juanatey Source Type: research

A Brugada-like electrocardiogram pattern induced after radiofrequency catheter ablation of atrial fibrillation
Radiofrequency catheter ablation(RFCA) of the left atrium(LA) targeting the initiating triggers inside the pulmonary vein(PV) to disconnect PVs has become a very promising and successful treatment in patients with symptomatic and drug refractory atrial fibrillation(AF) of no or minimal structural heart disease [1]. Known complications of RFCA have been defined and investigated, including pulmonary vein stenosis, aortic root and atrial perforation, stroke and pericardial effusion and so on [1,2].
Source: International Journal of Cardiology - August 23, 2014 Category: Cardiology Authors: Chunying Jiang, Rui Wang, Wen Lu, Bing Han Source Type: research

Predictive Value of Coronary Blood Flow for Future Cardiovascular Events in Patients with Atrial Fibrillation
Atrial fibrillation (AF) is associated with impaired coronary flow and diminished myocardial perfusion [1–3]. In a previous study, we demonstrated that patients with AF in the absence of obstructive coronary artery disease (CAD) have significantly higher Thrombolysis in Myocardial Infarction (TIMI) frame count (TFC) for all three coronary vessels compared to the control subjects without AF [1]. However, the clinical importance of the increased TFC in AF patients has not been fully elucidated, although TFC seems to be independently associated with mean platelet volume [4], an independent risk factor for future stroke and ...
Source: International Journal of Cardiology - August 22, 2014 Category: Cardiology Authors: Chufan Luo, Lichun Wang, Chong Feng, Wangjian Zhang, Zhibin Huang, Yuantao Hao, Anli Tang, Xiuren Gao Source Type: research

A Brugada-like electrocardiogram pattern induced after radiofrequency catheter ablation of atrial fibrillation
Radiofrequency catheter ablation (RFCA) of the left atrium (LA) targeting the initiating triggers inside the pulmonary vein (PV) to disconnect PVs has become a very promising and successful treatment in patients with symptomatic and drug refractory atrial fibrillation (AF) of no or minimal structural heart disease [1]. Known complications of RFCA have been defined and investigated, including pulmonary vein stenosis, aortic root and atrial perforation, stroke and pericardial effusion and so on [1,2].
Source: International Journal of Cardiology - August 23, 2014 Category: Cardiology Authors: Chunying Jiang, Rui Wang, Wen Lu, Bing Han Tags: Letter to the Editor Source Type: research

Predictive Value of Coronary Blood Flow for Future Cardiovascular Events in Patients with Atrial Fibrillation
Atrial fibrillation (AF) is associated with impaired coronary flow and diminished myocardial perfusion [1–3]. In a previous study, we demonstrated that patients with AF in the absence of obstructive coronary artery disease (CAD) have significantly higher Thrombolysis in Myocardial Infarction (TIMI) frame count (TFC) for all three coronary vessels compared to the control subjects without AF [1]. However, the clinical importance of the increased TFC in AF patients has not been fully elucidated, although TFC seems to be independently associated with mean platelet volume [4], an independent risk factor for future stroke and ...
Source: International Journal of Cardiology - August 22, 2014 Category: Cardiology Authors: Chufan Luo, Lichun Wang, Chong Feng, Wangjian Zhang, Zhibin Huang, Yuantao Hao, Anli Tang, Xiuren Gao Tags: Letter to the Editor Source Type: research

Comparative evaluation of HAS-BLED and ATRIA scores by investigating the full potential of their bleeding prediction schemes in non-valvular atrial fibrillation patients on vitamin-K antagonists
Although vitamin K antagonists (VKAs) greatly reduce the risk of stroke in non-valvular atrial fibrillation (NVAF), the risk of bleeding with this therapy remains challenging [1]. HAS-BLED [2,3] and ATRIA [4] are currently the most popular scoring systems for bleeding risk assessment in NVAF. Until now, the main studies [5–7] comparing both scores used “modified” versions of the original scores, while the current recommendation [3] is to use HAS-BLED as it was originally conceived. Furthermore, most of these studies came from a trial population or hospitalized patients [5,7].
Source: International Journal of Cardiology - August 7, 2014 Category: Cardiology Authors: Rami Riziq-Yousef Abumuaileq, Emad Abu-Assi, Sergio Raposeiras-Roubin, Andrea López-López, Alfredo Redondo-Diéguez, Diego Álvarez-Iglesias, Moisés Rodríguez-Mañero, Carlos Peña-Gil, Jose Ramón González-Juanatey Tags: Letter to the Editor Source Type: research

Relationship between macular and retinal disease with prevalent atrial fibrillation – an analysis of the Australian Heart Eye Study
Atrial fibrillation (AF) is the most frequent cardiac arrhythmia, which significantly and independently predicts morbidity and mortality. AF increases overall mortality risk by 40-90%, and may be associated with underlying cardiovascular disorders including stroke and heart failure [1]. Ocular diseases including diabetic retinopathy, age-related macular degeneration (AMD) and retinal vessel calibre changes are also significant predictors of cardiovascular disease and blood pressure [2]. However, their relationship with cardiac arrhythmias such as atrial fibrillation have been relatively unexplored.
Source: International Journal of Cardiology - October 22, 2014 Category: Cardiology Authors: Kevin Phan, Paul Mitchell, Gerald Liew, Sarah B. Wang, Adam J. Plant, Aravinda Thiagalingam, George Burlutsky, Bamini Gopinath Tags: Letter to the editor Source Type: research

Patterns of cardiovascular drugs prescribed for an elderly Swedish population
Cardiovascular diseases (CVDs), such as coronary heart disease, atrial fibrillation, heart failure and stroke, are increasingly common as people age. Therefore, cardiovascular drugs are the most frequently prescribed medications for preventive and therapeutic purposes among older adults [1]. However, several factors make cardiovascular drug treatment in elderly people complicated. Age-related pathophysiological changes in the cardiovascular system, liver and kidney can affect the pharmacokinetics and pharmacodynamics of commonly used drugs, which makes older persons more vulnerable to adverse drug events [2].
Source: International Journal of Cardiology - October 7, 2014 Category: Cardiology Authors: Mozhu Ding, Rui Wang, Kristina Johnell, Chengxuan Qiu Tags: Letter to the Editor Source Type: research

Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation: The Catanzaro atrial fibrillation project
Atrial fibrillation (AF) is the most common cardiac rhythm disorder in adult and old subjects with an increased risk for stroke, mortality and hospitalizations with a significant impact on health care economic costs [1]. Several clinical conditions are recognized as risk factors for AF [2] and they are able to significantly increase the risk of future cardiovascular (CV) events [3].
Source: International Journal of Cardiology - October 4, 2014 Category: Cardiology Authors: Francesco Perticone, Angela Sciacqua, Maria Perticone, Eliezer J. Tassone, Giorgio Sesti, Francesco Violi, Gregory Y.H. Lip Tags: Letter to the Editor Source Type: research

Thromboembolic risk in the initiation, switch and interruption/re-initiation of oral anticoagulants: Do newcomers improve outcomes? Insights from a meta-analysis of RCTs.
Anticoagulation is the cornerstone treatment in patients with atrial fibrillation for stroke prevention. In the last decades, oral vitamin K antagonists (VKA) have been the most used drug of this class. The clinical management of these patients is not straightforward due to the need of periodical evaluation of the INR, as well as due to the numerous drug-drug and drug-food interactions. In addition, recent studies have provided new insights of potential problems associated to VKA treatment:
Source: International Journal of Cardiology - September 27, 2014 Category: Cardiology Authors: Daniel Caldeira, João Costa, Joaquim J. Ferreira, Fausto J. Pinto Tags: Letter to the Editor Source Type: research